The German newspaper Welt am Sonntag, citing an anonymous German government official, reported Sunday that the Trump administration offered CureVac $1 billion to hand the U.S. exclusive rights to a potential COVID-19 vaccine.
Trump wants the vaccine “only for the USA,” the German official said. The New York Times confirmed late Sunday that the Trump administration attempted to persuade CureVac to move its research to the U.S., offering the company what one German official described as a “large sum” of money. Continue reading.